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Recently, world events have focused public attention
on chemical munitions or chemical warfare agents. The
renewed threat of chemical warfare has become apparent in
Iraq's use of chemical weapons against Kurdish civilians
and Iranian military personnel (United Nations Security
Council, 1984-1987). In addition, the widespread
possession of such weapons raises the issue of chemical
warfare proliferation to other conflicts or to terrorist
activity (Orient, 1989). Other recent world events, such
as the reunification of Germany and the Gulf War, have
raised concerns regarding public access to former military
sites where chemical munitions were manufactured, stored,
or armed (Watson and Griffin, 1992). Domestic attention to
chemical munitions has also been sparked by the
congressional mandate to destroy the aging U.S. unitary
stockpile of organophosphates via incineration (Munro et
al., 1994). Unitary weapons contain lethal agents at the
time of assembly, in contrast to binary weapons which
contain agent precursors that mix upon firing and react to
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form lethal agents (Munro, 1990). Hence, the deteriorating
unitary weapons stockpile poses a threat in storage as well
as in handling during disposal. Organophosphates such as
agents GA [ethyl-N,N-dimethylphosphoramidocyanidate/tabun] ,
GB [isopropylmethylphosphonofluoridate/sarin], and VX
[O-ethyl-S-(2-diisopropylaminoethyl)methylphosphonothiolate], which
comprise most of the stockpile (fig. 1), were designed to
cause incapacitation or death in military use. They exist
in the form of various weapons, i.e., bombs, cartridges,
mines, projectiles, rockets, spray tanks, and ton
containers (Munro et al., 1990).
Toxicity of Organophosphates
As weapons, these compounds are extremely effective
upon release due to their high toxicities at low doses. In
vapor or aerosol form, these nerve agents can be inhaled or
absorbed through the skin or the conjunctiva of the eye; as
a liquid, they can be absorbed through the skin,
conjunctiva and upper gastrointestinal tract (Grob and
Harvey, 1953). Since they are essentially colorless,
odorless, tasteless, and nonirritating to the skin, their
entry into the body may not be perceived by the individual
until grave signs and symptoms appear (Munro et al., 1994).
However, their effects on individuals range from none to
life threatening, depending on the type and concentration
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Figure 1: Organophosphorus esters that comprise the United
States' stockpile of unitary chemical munitions. GA
[tabun; N,N-dimethyl phosphoroamidocyanidate ethyl
ester], GB [sarin; methylphosphonofluoridate isopropyl
ester] and VX [S-{diisopropylaminoethyl)
methylphosphonothiolate o-ethyl ester] are
organophosphorus esters that form a major portion of the
total agents comprising the United States' stockpile of
unitary chemical munitions (Munro et al., 1994).
[Molecular structures of GA, GB, VX adapted from Dacre et
al. and Gordon et al. ]



















of the agent released, the duration of exposure, individual
variation in sensitivity and the availability of antidotes,
decontamination and treatment capability (Munro et al.,
1994) . Even so, exposure to low levels of nerve agent
vapor results in constriction of the pupils for several
days or a prolonged myosis persisting for several weeks
(Rengstorff, 1985; Sidell, 1974) and pain and/or dim vision
(Sidell, 1990). Bronchoconstriction, excess secretion in
air ways, wheezing, and labored breathing comprise the
respiratory effects (Sidell, 1990). Moderate systemic
effects, which partly depend on the route of exposure,
ensues within seconds to two minutes after inhalation,
within 45 minutes following ingestion, and 2-18 hours
following topical application on the skin (Grob and Harvey,
1953; Bowers et al., 1964). However, Robinson (1967)
reports that lethal dose exposure can lead to collapse
within seconds following a single deep inhalation and
death within 10 minutes.
Mechanism of organophosphate action
The toxic action of these compounds is principally due
to inhibition of acetylcholinesterase (fig. 2) . Excessive
acetylcholine acciamulation at synapses results in
overstimulation of the portions of the nervous system that
control smooth muscle, skeletal muscle, cardiac muscle, and
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Figure 2: Acetylcholinesterase activity. In aqueous medium,
acetylcholinesterase hydrolyses acetylcholine to yield




CH^CHOCH-N-CH^ +3 2 ' '* HO ► CH3C-OH + HOCH2CH2-N-CH3
CH3 CH3
Acetylcholine Water Acetic Acid Choline
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exocrine glandular function which result in the following
symptoms: drooling, increased bronchial secretions,
bronchoconstriction, myosis, excessive sweating, vomiting,
diarrhea, abdominal cramping, involuntary urination,
cardiac arrhythmias, twitching and fasciculation, cramping,
and even flaccid paralysis (Munro et al., 1994).
Overstimulation of the central nervous system (CNS) via
acetylcholine accumulation also results in headache,
anxiety, restlessness, irritability, giddiness, insomnia,
nightmares, convulsions and coma, depending on the agent
and the dosage (Grob and Harvey, 1953). However,
respiratory failure, which represents an effect that occurs
as the result of acetylcholine accumulation at several
sites in the nervous system, is the primary cause of death.
Depression of the brain's respiratory center, neuromuscular
block of the respiratory muscles, bronchial constriction,
and increased lung secretions all contribute to nerve agent
induced respiratory failure (Munro et al., 1994).
Relevance of biochemical indices of organophosphate
exposure
The impact of nerve agents on human physiology is
severe. As such, biochemical indices of nerve agent
exposure are currently sought. Hence, the enzyme
acetylcholinesterase has been targeted (Aldridge, 1950;
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Franciskovic et al., 1993; Busker et al., 1994). Attempts
to measure blood acetylcholinesterase activity as an
indicator of nerve agent exposure and/or the severity of
clinical symptoms have been made (Munro et al., 1994). In
addition, monitoring the reappearance of
acetylcholinesterase activity has also been attempted as an
index of recovery (Munro et al., 1994). However, a clear
correlation between levels of acetylcholinesterase
inhibition following organophosphate intoxication, and
clinical symptoms does not exist since all
acetylcholinesterase molecules may not be involved in
breaking down synaptic acetylcholine (Hobbiger, 1976;
Clement et al., 1987; Van Dongen et al., 1988; Clement,
1989; Jimmerson, et al., 1989; Van Dnogen and Wolthuis,
1989; Melchers and Van Helden, 1990; Clement, 1993).
Since organophosphates are essentially colorless,
odorless, tasteless, and nonirritating to the skin, their
entry into the body may not be perceived by an individual
until grave symptoms appear (Munro et al., 1994). Hence,
the importance for an indicator of nerve agent exposure is
greatly amplified. The hepatic detoxification enzyme,
glutathione S-transferase, may serve as such an index.
Glutathione S-transferase (GST) conjugates potential
electrophiles/xenobiotics to glutathione to form an adduct.
Since, this adduct is less reactive and more water soluble
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than the parent compound, excretion via the bile salts can
take place. If hepatocellular toxicity were to ensue, i.e.
munitions exposure, elevated levels of GST would appear in
the blood. Hence, elevated GST in blood would be
indicative of hepatocellular insult. In addition, these
enzymes possess the capacity to interact with novel
organophosphates (Lyttle, 1993). These interactions may be
measured in serum via kinetic studies. Hence, individuals
exposed to sublethal doses of these agents, may begin to






As reported by Meister (1980), in 1879 Baumann,
Preusse and Jaffe demonstrated that the administration of
bromobenzene and chlorobenzene to canines resulted in
urinary excretion of compounds referred to as mercapturic
acids or S-substituted derivatives of N-acetylcysteine
(Boyland and Chasseaud, 1969). The source of the cysteine
residue was thought to be derived from dietary proteins.
However, in 1937, Stekol refuted this idea upon
supplementing the food of animals with glutathione
(reported by Boyland and Chasseaud, 1969). There was no
net increase in mercapturic acid formation resulting from
the diet or from depletion of cysteine from tissue
proteins. Several mechanisms of mercapturic acid formation
were proposed (Stekol, 1939; Smith et al., 1950; Mills and
Wood, 1956; Barnes et al., 1959; Bray et al., 1959;
Waelsch, 1930; Brand and Harris, 1933). It was Booth and
his colleagues in 1961, who isolated a protein/enzyme that
catalyzed conjugation of glutathione with foreign
compounds, including some that were metabolized to
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mercapturic acids (fig. 3). Grover and Sims (1964)
referred to this enzyme as glutathione S-aryltransferase
because of its apparent specificity for glutathione and
compounds possessing an aromatic ring. Several other
enzymes capable of catalyzing glutathione conjugation were
later discovered and purified. These enzymes are
collectively known as glutathione S-transferases.
Glutathione S-transferases (GSTs) are comprised of (1)
glutathione S-aryltransferase, (2) glutathione
S-epoxidetransferase, (3) glutathione S-alkyltransferase,
(4) glutathione S-aralkyltransferase, and (5) glutathione
S-alkenetransferase (Boyland and Chasseaud, 1969).
However, Jakoby (1980) contends that the term "Glutathione
Transferases" is a misnomer since these enzymes should not
be viewed as participating in only the transfer of
glutathione, but rather as proteins that catalyze any
reaction in which glutathione thiolate anion participates.
GSTs catalyze the conjugation of GSH to xenobiotics and
other electrophilic compounds possessing aromatic and other
cyclic rings that have labile nitrogen or halogen groups.
These proteins may exist in soluble and membrane-bound
forms. Glutathione S-transferases collectively represent a
family of dimeric and trimeric enzymes which have been
isolated in the cytosol and microsome fractions,
respectively (Hayes et al., 1991; Adams and Sikakana,1990).
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Figure 3. Outline of the biochemistry/metabolism of GSH. AA,
amino acids; X, compounds that react with GSH to form
conjugates. 1, Y-glutamylcysteine synthetase; 2, GSH
synthetase; 3, Y-glutamyltranspeptidase; 4, dipeptidases;
5, Y-glutamylcyclotransferase; 6, 5-oxoprolinase; 7, GSH
s-transferases; 8, N-acetyltransferase; 9, GSH
peroxidases; 10, GSH thiol transferases; 11, reaction of
free radicals with GSH; 12, glutathione disulfide (GSSG)
reductase; 13, transport of Y-Glu-(Cys)2 (Meister, 1989).
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The membrane-bound microsomal GST, which is less active
than cytosolic GST, represents only one type, while all the
other types can be found in the cytosol (Meikle, et al.,
1991) . Hence, only the cytosolic form will be considered
here since those are the forms dealt with in this study.
These enzymes may be found in various species, from
Escherichia coli to humans, and may exist as homodimers or
heterodimers (Pickett, 1989; Adams and Sikakana, 1990;
Ivanetich and Goold, 1989). Each subunit is found to have
a molecular weight ranging from 17kd to 2 6kd and is
characterized on the basis of its isoelectric point (Hayes
et al., 1991; Habig and Jakoby, 1981). Approximately
eleven subunits have been identified in the rat and, in the
nomenclature used, each subunit is given a number in the
chronological order of its characterization (Jakoby et al.,
1984). The complete amino acid sequences have been deduced
for subunits 1 (Pickett et al., 1984; Lai et al., 1984), 2
(Telakowski-Hopkins et al., 1985), 3 (Ding et al., 1985), 4
(Lai et al., 1988), 6 (Abramowitz and Listowsky, 1987) and
7 (Suguoka et al., 1985). Mannervik et al., (1985),
Mannervik (1985), Juronen et al., (1996), and Kempkes et
al., (1996) report that the sequences, based on structural
data (Table 1), suggest that the subunits fall into four
categories or classes: the alpha class (subunits 1 and 2),
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Table 1: Similarities of glutathione s-transferases
Transferases (pi) Amino-terminal amino acid sequences
Class alpha*(pl>8)
Rat 1-1 (cDNA) ikfSGKPVLHYFNARGRMECIRWLLAAA
Rat 1-2 PGKPVLHYFNGRGRMEPI
Rat 2-2 P GKP VL/f YF
Rat 2-2 (cDNA) MPGKPVLHYFDGRGRMEPI
Class mu (pi 6.5)
Human PMILGYWDIRGLAHAIRLLLEYT




Class pi (pi 4.8)
Human n PPYTVVYFPVRGRCAALRMLLAD
Rat 7-7 PPYY IVYFPV
Mouse Mill PPYTIVYFPVVDGCEAM
Class theta (pi ?)
Human 0 current^ being determined
Rat 5-5 currently being determined
Mouse T1 -1 partially purified
Microsome (pi ?) Lacks homology with any of the cytosolic isozymes.
‘Class alpha also comprises human transferases a-6 and mouse transferase ML. These proteins are amino-terminally
blocked and are not listed owing to lack of sequence information. Italicized residues indicate tentative assignments or
initiator methionine.
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the mu class (subunits 3, 4, and 6) , the pi class (subunit
7), and the recently discovered theta class.
The mode of action of these enzymes is presently
unclear. Unlike other prominent conjugation processes, GSH
conjugation does not require utilization of ATP (Chasseaud,
1979). Al-Kassab et al. (1963) suggested that rat GST
provided a "charged" GSH for conjugation with an
electrophile. The rate of the non-enzymatic reaction of
the electrophilic substrate with GSH increases
proportionately to the increase of ionized GSH (Chasseaud,
1979) . This outcome, therefore, suggests that GS“ is the
reacting nucleophile. Keen et al. (1976) reported that
human (alpha class; see Table 1), P and 6 GSTs promote
ionization of the sulfhydryl group of GSH by lowering its
pK (pK = 9.2) and thereby increasing its nucleophilicity
(fig. 4) . In addition, GST would bind the electrophile,
promoting preferential interaction with the GS“ anion.
Reduction of the pK of the GSH thiol is thought to be a
major contributor to GST's mode of action. Awasthi et al.
(1987) contended that a single histidine residue is
responsible for this reduction, since substitution of a
single histidine residue with a basic group resulted in the
loss of human y GST activity (Table 1) . It has also been
suggested that an arginine residue is associated with GSH
binding and anion recognition (Schasteen et al., 1983).
14







Reduced Glutathione Ionized Gluuthione
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On the other hand, Kong et al. (1992) reported that a
tyrosine residue on human it GST is responsible for GSH
ionization.
Characterization of the kinetic mechanism of GST is
equally perplexing. Investigators have reported that
studies on YaYa GST from male Sprague-Dawley rats suggest
that the kinetic mechanism of substrate addition is likely
to be random (Schramm et al., 1984). In addition,
competitive inhibition studies revealed a single binding
site for a product analog. This occurrence is consistent
with the presence of a single catalytic site (Schramm et
al., 1984). Danielson and Mannervik (1988) reported that
GST from rat liver exhibited paradoxical inhibition which
may be explained by substrate-inhibitor-enzyme complexes in
a random-order sequential mechanism. However, experimental
support for kinetically significant conformational changes
under steady-state conditions is lacking. Ivanetich and
Goold (1989) also endorsed the rapid random equilibrium
sequential Bi Bi mechanism for human placental glutathione
S-transferase (Ivanetich and Goold, 1989). In addition,
these investigators suggested that the kinetic mechanism of
the GST is isoenzyme-dependent. Some isoenzymes (for
example rat's YaYa GST) appear to follow conventional
hyperbolic kinetics while others (for example rat's 2-2,
3-3, 3-4 GSTs) exhibit non-hyperbolic kinetics (Schramm et
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al., 1984; Ivanetich et al., 1990). The steady-state
random sequential Bi Bi mechanism may be sufficient to
explain the latter phenomenon in rat hepatic GST isoenzymes
(Ivanetich et al., 1990). Phillips and Mantle (1991)
reported that by using a computer simulation program
(EKPLOT) a model was developed that suggested the presence
of an allosteric site on mouse GST YfYf. Perhaps this
allosterism accounts for the deviation from hyperbolic
Jcinetics.
Aside from conjugating potential electrophiles to
glutathione, it has been reported that human GST has the
capacity to activate particular compounds. Lyttle et al.
(1993) have shown that GST activates novel alkylating




Compounds 1, 2, 3 will be referred to as T230, T231, and
T286 respectively. The proton extracting moiety of GST is
presumed to deprotonate the carbon a to the sulfone, which
then undergoes p-elimination to give the species shown in
figure 3 (Lyttle et al., 1993). In addition, a cytotoxic
phosphate moiety is liberated. This moiety is then able to
interact with macromolecules, perhaps even at the DNA level
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Figure 5: GST's activation of the organophosphates. The
proton extracting moiety of GST is presumed to
deprotonate the carbon a to the sulfone, which then
undergoes p-elimination to give the species shown (Lyttle
et al. 1993).









as proposed by Colvin and Holden (1981) . However, it may
also phosphorylate proteins, as in the case of other
organophosphate interactions with acetylcholinesterase
(Aldridge, 1950). If GST is alkylated or phosphorylated by
the nitrogen mustards then monitoring the morphological and
kinetic alterations of GST, the aim of this study, may
prove to be a useful biomarker for nerve agent exposure.
Hence, this study will attempt to show that the
nitrogen mustards are cytotoxic. In addition. the
mutagenic potential of the test agents will be assessed.
This study will attempt to demonstrate that GST is capable
of "activating" these compounds and in so doing exposes
itself to the reactive and cytotoxic phosphate moiety. An
attempt will also be made to determine the GST isoform with
the highest activational efficiency. This study will also
attempt to determine whether the nitrogen mustards induce
any conformational alterations in glutathione
S-transferase. The kinetic efficiency of GST will be
determined prior to and following nitrogen mustard exposure
of HEP-G2 cells. As such, determination of the isoform
most susceptible to kinetic and conformational





Untreated human hepatoma cells (cell line HEP-G2) were
purchased from the American Type Culture Collection. The
HEP-G2 cells were incubated (in 5% CO2) in sterile 75cm^
flasks at 37°C in complete medium i.e., 0.5L Dulbecco's
Modified Eagle's Medium (DMEM) with 4.5g glucose/L,
supplemented with 10% Fetal Bovine Serum and an
Antibiotic-Antimycotic mix (penicillin, streptomycin and
amphotericin B) . The cells were kept in log phase by
weekly subculture.
Subculture
Subculturing entailed decanting the medium and washing
the cells twice with 5 ml Hanks Balanced Salt Solution.
The salt solution was then decanted and the cells were
incubated with 2.5 ml trypsin/EDTA for 2-5 minutes for cell
detachment. The detached cells were then transferred to a
sterile culture tube and centrifuged at approximately 1000
X g for 4 minutes. The supernatant was decanted and the
pelleted cells were resuspended in 2 ml DMEM.
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The cells were then aliquoted, 0.2 ml per 10 ml medium,
into culture flasks.
Cryopreservation
Cells chosen for freezing were healthy (>97% viable) ,
mid-log-phase cultures. The cells were pelleted by gentle
centrifugation (1000 x g for four minutes). The old media
was decanted and discarded after which the cells were
resuspended in fresh sterile filtered medium to a density
of 1 to 2 X lo”^ cells/ml. The cell suspensions were then
diluted with an equal volume of freshly prepared freezing
medium which was the complete medium, as described earlier,
supplemented with 10% DMSO. An appropriate volume (usually
1.0 ml/vial) was aliquoted into each cryovial and capped
tightly. The cells were then frozen slowly. As such, the
vials were placed into an insulated container at -20°C for
1 hour and then placed at -70°C overnight. Alternatively,
the vials were placed in an appropriate freezing container
which were placed at -70°C overnight. The vials were
transferred to liquid nitrogen the following day for
long-term storage. One to two weeks after the cells had
been placed in liquid nitrogen, one vial was thawed to
check for viability and contamination.
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Thawing Cells
Ten milliliters of complete medium were added to a 25
cm^ tissue culture flask. A cryogen vial was removed from
liquid nitrogen and thawed rapidly with gentle agitation at
37°C. The outside of the cryogenic vial was decontaminated
by immersing it in 70% ethanol at room temperature; after
which, the contents of one vial were aseptically
transferred to the 25 cm^ tissue culture flask. Since
HEP-G2 cells grow as a monolayer culture, the cells were
incubated at 37°C for 24 hours and examined to determine
whether the cells attached to the surface of the flask. If
the cells were not attached to the surface of the flask
after this time, the cells were discarded and another
cryogenic vial was thawed. However, when the cells were
attached, the media was discarded and replenished with 10
ml of fresh, complete media. The cells were then incubated
at 37°C until confluent.
Cell Counting
HEP-G2 cells were counted via Sigma Chemical's in
vitro Toxicology Assay Kit. Briefly, 1% (w/v) neutral red
in media was added to each well of a 96-well microtiter
plate. Upon incubation for 30 minutes, the excess dye was
aspirated. The remaining dye was removed by 4 serial
washes of the microtiter plate in phosphate buffered saline
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(pH 7,2). Alternatively, the cells were fixed in 1% CaCl2
: 0.5% formalin. The cell layer was then examined
microscopically. The dye was eluted by adding 100|iL of 1%
acetic acid : 50% ethanol to each well. The plate was
shaken gently and the absorbance at wavelength 540nm (A^^q)
was measured using a microplate reader. The microplate
reader was "blanked" using the elution solvent prior to
each measurement.
Cell Harvest
The medium was decanted by aspiration. The cells were
washed twice with 5 ml (4°C) saline. The saline solution
was then decanted and 0.5 ml of 0.01 M potassium phosphate
buffer with 0.1% KCl (pH 7.2) was added to the flask. The
cells were detached from the flasks' surface with trypsin
incubation for approximately 5 minutes followed by
homogenization using a motor driven pestle. The homogenate
was centrifuged at 10,000 x g in a Beckman J2-21 centrifuge
at 4°C for 30 minutes. The supernatant was decanted and
stored at -70°C until needed.
Cytotoxicity Test
HEP-G2 cells were plated (1,500 cells/100 |i-L) in 6
well plates at least 24 hours prior to exposure to the
nitrogen mustards (test agents). The test agents used were
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mustard simulants obtained from Lyttle et al. Simulants
were used because of the extreme safety hazard associated





The test agents were dissolved in 0.2% DMSO prior to mixing
in media. The cells were incubated with increasing
concentrations of the agents for 1-24 hours (as indicated
in individual experiments) , after which the media was
changed to the standard medium lacking the mustards. The
cells were then grown for 8 days and surviving cells were
counted and compared to the control (vehicle treated) cells
which did not significantly differ from that of the
untreated control.
-Mutagenicity Test-
The tester strains TA98, TAIOO, and TA102 of Salmonella
typhimurium, were processed immediately upon receipt from
Bruce Ames' laboratory. The packets were cut open
immediately with sterile scissors and the culture discs
were removed with sterile forceps. The discs were placed
into a culture tube or bottle containing 20 ml oxoid
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nutrient broth #2, Five milliliters of culture were grown
in 18 X 150 mm culture tubes with loose fitting caps.
Cultures were incubated at 37°C in a gyrotory incubator and
shaken at approximately 210 rpm. The growth period did not
exceed 16 hours to minimize the loss of viability. Hence,
the cultures were removed from the incubator immediately
after reaching a density of 1-2 x 10^ cells per milliliter
as determined via turbidity measurements at 650 nm. The
culture tubes were then wrapped with aluminum foil to
protect the bacteria from light. The cultures were stored
as frozen permanents at -80°C or on master plates at 4^C
until they were needed.
-Storage of Tester Strains-
Cryopreservat ion
Upon growth of the tester strains in oxoid broth #2,
10% DMSO was added to the culture in a sterile culture
tube. The culture tube was swirled gently until
homogeneity was achieved. The culture was then aseptically
distributed in sterile 1.2 ml cryovials which were labeled
appropriately. The vials were nearly filled, allowing for
expansion due to freezing, eliminating air space and
minimizing oxidative damage. The cryovials were then
immersed in liquid nitrogen until the culture was frozen
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solid. The cryovials were then transferred to a -80°C
freezer.
Master Plates
A cryovial containing frozen permanents was thawed.
One drop of thawed culture was applied to the surface of a
histidine/biotin plate [15g agar/L, IX VB salts {50X
Vogel-Bonner medium: 10 g magnesium sulfate (MgSO^*? H2O),
100 g citric acid monohydrate, 500 g anhydrous potassium
phosphate, dibasic (K2HPO4), 175 g sodium ammonium
phosphate, final volume was raised to IL with warm
distilled H2O}, 2% glucose, 3 p,M biotin, 32 mM histidine].
The plate was streaked out for single colony isolation
using a sterile inoculating loop. The plate was incubated
for 48 hours at 37°C. A well-isolated colony was removed
with a sterile inoculating loop and resuspended in 0.3 ml
or less of phosphate-buffered saline in a sterile culture
tube. A sterile cotton swab was used to inoculate the
surface of the appropriate agar plate via 4 to 5 parallel
streaks with the resuspension. The plates were incubated
overnight at 37°C. The master plates were then stored at
4*^C and discarded after 2 weeks.
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-Confirming Genotypes of Tester Strains-
Histidine requirement
Upon receiving the cultures, the tester strains'
genotype was confirmed. Fresh broth cultures were used for
these tests. A sterile inoculating loop was used to make a
single sweep of the tester strains across biotin [15g
agar/L, IX VB salts {50X Vogel-Bonner medium: 10 g
magnesium sulfate (MgS04 • 7 H2O), 100 g citric acid
monohydrate, 500 g anhydrous potassium phosphate, dibasic
(K2HPO4), 175 g sodiiim ammonium phosphate, final volume
will be raised to 1 L with warm distilled H2O}, 2% glucose,
32 mM histidine] and histidine control plates [15g agar/L,
IX VB salts {50X Vogel-Bonner medium: 10 g magnesium
sulfate (MgS04"7 H2O), 100 g citric acid monohydrate, 500 g
anhydrous potassium phosphate, dibasic (K2HPO4), 175 g
sodium ammonium phosphate, final volume was raised to 1 L
with warm distilled H2O}, 2% glucose, 3 jiM biotin] followed
by a sweep across biotin/histidine plates [15g agar/L, IX
VB salts {50X Vogel-Bonner medium: 10 g magnesium sulfate
(MgS04"7 H2O), lOOg Citric acid monohydrate, 500 g
anhydrous potassium phosphate, dibasic (K2HPO4), 175 g
sodium ammonium phosphate, final volume was raised to 1 L
with warm distilled H2O}, 2% glucose, 3 p,M biotin, 32 mM
histidine]. All three strains can be tested on each plate.
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The strains were identified by labelling each streak with a
marking pen on the bottom of the petri plate. The plates
were incubated overnight at 37°C and examined for growth on
the histidine/biotin plates.
rfa mutation
Nutrient agar plates [0.8% (w/v) Difco bacto nutrient
broth NaCl, 0.5% (w/v) NaCl, 1.5% (w/v) agar] were
streaked with a different tester strain. One-tenth
milliliter of fresh overnight culture of each tester strain
was added to a sterile culture tube containing 2 ml of
molten top agar [0.6% (w/v) agar, 0.5% (w/v) NaCl] held at
4 5°C. The culture tube was vortexed for 3 seconds at low
speed and poured on a nutrient agar plate. The plate was
rotated and tilted to ensure an even distribution of the
top agar followed by allowance for polymerization on a
level surface. Ten microliters of a 1 mg/ml solution of
crystal violet was pipetted onto sterile filter paper discs
(1/4 inch diameter) and transferred (a single filter per
plate) to each seeded plate with sterile forceps. The disc




Nutrient agar plates were prepared as previously
described. A different sterile loop was used for
inoculation from the cryovials containing the different
tester strains. A single sweep across the nutrient agar
plate was made. Each streak was labeled with a pen on the
bottom of the petri plate. The plates were incubated
overnight at 37°C and examined for growth. Upon removal
from the incubator, cardboard was placed over the uncovered
plate so that half of each bacterial streak was uncovered.
The plates were then irradiated with a 30W germicidal lamp
at a distance of 33 cm for 4 seconds and incubated
overnight at 37°C.
R-factor
A sterile loop was used to inoculate ampicillin plates
[1.5% (w/v) Agar, IX VB salts, 2% glucose, 260 |iM
histidine, 3 biotin, 25 ^ig ampicillin/ml 0.02 N NaOH]
and ampicillin/ tetracycline plates [1.5% (w/v) Agar, IX VB
salts, 2% glucose, 260 |iM histidine•HCl'water, 3 biotin,
25 ng ampicillin/ml 0.02 N NaOH, 2 ng tetracycline/ml 0.02N
HCl] from the frozen permanents containing different
strains. A single sweep across each plate from the
different frozen permanents was made. Each streak was
labeled with a pen on the bottom of the petri plate. The
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plates were incubated overnight at 37°C and examined for
growth.
-Re isolation of tester strains-
A sterile inoculating loop immersed into a freshly
thawed permanent culture was used to make a single streak
across the surface of the minimal glucose agar plate or
"bottom agar" [1.5% (w/v) Agar, IX VB salts, 2% glucose].
The culture was cross-streaked using a sterile inoculating
loop. The plates were incubated for 48 hours at 37°C. A
well-isolated colony was selected for overnight growth in
Oxoid nutrient broth No. 2. New frozen permanents were
prepared from these liquid cultures.
-Plate Incorporation Test-
On the day preceding the experiment, fresh nutrient
oxoid broth culture was grown overnight for the strain(s)
of bacteria at 37°C in a shaker water bath. Small 12x75mm
tubes were maintained at a temperature of 45°C via a
heating block. The top agar was heated on a hot plate or
in a microwave. Ten milliliters of histidine/biotin
solution [0.5 inM biotin, 0.5 mM histidine] were added to
100 ml of the top agar. Two milliliters of the top agar
were distributed into the 12x75mm capped culture tubes in
the heating block. The S9 mix [0.1 M phosphate buffer(pH
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7.4), 4 mM NADP, 5 mM glucose phosphate, 0.4 M MgCl2/ 1.65M
KCl, 0.04% (v/v) rat liver S9 (Aroclor-induced)] was
prepared. One-tenth milliliter of the fresh overnight
culture of the test strain, 0.1ml of test agent, and 0.5ml
of the S9 mix were quickly added to the tubes. The test
agents were tested in the presence and absence of the S9
mix. Both positive and negative control plates were
included in the assay. Negative controls contained the
bacteria (tester strain) , S9 mix and solvent but no test
chemicals. Positive controls contained the bacteria (tester
strain), S9 mix, solvent and standard diagnostic mutagens.
The diagnostic mutagens were sodium azide and
2-aminofluorene. Triplicate plates were poured for each
dose of mutagen. The test components were mixed by
vortexing the soft agar for 3 seconds at low speed and then
poured onto a minimal glucose agar plate. To achieve a
uniform distribution of the top agar on the surface of the
plate, the plate was quickly tilted, rotated and placed on
a level surface to polymerize. The mixing, pouring and
distribution took less than 20 seconds and the plates were
left to polymerize for several minutes. The plates were
covered promptly to avoid the effects of light on
photosensitive chemicals. Within an hour, the plates were
inverted and placed in a dark vented 37°C incubator. After
48 hours the revertant colonies on the test plates and on
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the control plates were counted and the presence of the
background lawn on all plates was confirmed. Colonies
appearing on a plate that had no background lawn were not
revertants and were not scored. These colonies would have
arisen from the surviving bacteria that utilized the
histidine present in the top agar.
-Cholinesterase Kinetic Assay-
Human erythrocyte acetylcholinesterase (AchE) was
purchased from Sigma Chemical Co. (0.62 units/mg solid;
one unit will hydrolyze 1/umole of acetylcholine to choline
and acetate per min at pH 8 at 37°C.) In addition,
quantitative kinetic determination of cholinesterase
activity was determined via the use of a cholinesterase
kinetic diagnostic kit purchased from Sigma Chemical Co.
The active reagents included 5mM butyrylthiocholine iodide,
0.25mM 5,5'-Dithiobis-2-Nitrobenzoic acid (DTNB), buffer
(pH 7.2 ± 0.1), nonreactive stabilizers and fillers. The
dry reagent was refrigerated at 4°C. Although the
reconstituted reagent is stable for 4 hours at room
temperature and for 3 days if refrigerated, it was prepared
fresh for each assay.
The procedures were followed as outlined in the kit.
Briefly, 5^ig AchE were used for each assay, unless
otherwise indicated. The concentration of
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butyrylthiocholine was varied between O.SitiM and 5rnM.
Hence, the kinetic reactions were monitored over a 10-fold
concentration range. The sample/reagent ratio was
maintained at 1:100. A Beckman DU-650 spectrophotometer,
equipped with enzyme kinetic applications, was used to
monitor the kinetic reactions at 405nm for one minute at
30°C.
Cholinesterase activity was determined as follows:
Butyrylthiocholine + H2O AchE > Butyrate + Thiocholine
Thiocholine + DTNB > 5-Thio-2-Nitrobenzoic acid
Activity (U/L)= (AAbs405nin per min x TV x 1000)/(13.6 x LP x SV)
= AAbS405ni[i ^ 7426
where:
AabS4Q5j^ = Change in absorbance per minute at 405nm
TV = total volume
SV = sample volume
13.6 = absorptivity (mM) of 5-thio-nitrobenzoic acid
LP = lightpath
1000 = conversion of units per milliliter to U/L
33
-Purification of GST from HEP-G2 Cells-
HEP-G2 cells were grown in culture to provide a source
of GST. The cells were then harvested and homogenized on
ice at 4°C. The homogenate was concentrated to a volume of
1 ml via an Amicon ultrafiltration unit. The 1 ml sample
was layered on a glutathione-agarose affinity column and
eluted with three buffers: (A) 10 mM Tris HCl, pH 8, (B)
10 mM Tris HCl, pH 8, with 5mM GSH, (C) 10 mM Tris HCl, pH
8, with 0.1 M KCl. The eluent containing 0.1 M KCl was
dialyzed against buffer A using the Spectra/Pore molecular
porous membrane with a molecular weight cut-off of
6000-8000 daltons. The eluents and dialysate were then
concentrated to 5 ml via ultrafiltration. The protein
content of the samples was determined by means of Bio Rad's
microprotein assay.
Protein Assay
Briefly, 0.8 ml of standards (known quantities of
bovine serum albumin) and appropriately diluted samples
were placed in clean, dry test tubes. The "blank"
consisted of 0.8 ml sample buffer. The contents of each
test tube was vortexed, avoiding excess foaming, following
the addition of 0.2 ml BioRad's dye reagent concentrate.
After an incubation period of 15 minutes at room
temperature, the 005^5 versus the reagent blank was
34
determined using the Beckman DU-650 spectrophotometer. A
standard plot of 00595 versus concentrations of standards
was generated from which the concentrations of the unknown
samples were determined.
Determination of the Subunit Composition of GST
SDS-PAGE was employed to assess GST subunits [prepared
according to the method of Laemmli (1970)]. Fifteen
milliliters (15 ml) of deionized 30%
acrylamide:bisacrylamide (29:1) were mixed with 15 ml of
1.5 M Tris base (pH 8.8 with HCl) containing 0.4% (v/v) SDS
and lOO^iL of ammonium persulfate (100 mg/ml made on the day
of use) . The volume was brought to 60 ml with deionized
water. This yielded a 7.5% separation gel. Thirty
microliters (30 ^L) N,N,N^,N^-Tetramethylethylenediamine
(TEMED) were added to catalyze polymerization. A Bio-Rad
Protean II xi gel electrophoresis cell was utilized and the
manufacturer's instructions were followed for assembly.
The 60 ml unpolymerized gel mix was poured into the
prepared plates and gently layered with a few milliliters
of saturated butanol/H20 to form a flat surface while the
acrylamide polymerized. After one hour, the butanol/H20
was decanted, and a top "stacking" gel [1 ml 30%
acrylamide/bisacrylamide, 4 ml H2O, 5 ml 0.25 M Tris, pH
6.8, 0.2% (v/v) SDS, 100 |iL ammonium persulfate, 7 jiL
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TEMED] was poured to fill the upper 3 cm of the gel.
This yielded a 3% stacking gel. The well-forming comb was
inserted and the stacking gel allowed to polymerize. The
gel was attached to the electrophoresis unit and
approximately 1.5 L IX electrode buffer [0.025 M Tris base
with 14.4 g glycine, 0.1% (v/v) SDS] were added to the
bottom chamber and 500 ml were added to the top chamber.
Ten microliter (10 |iL) samples (1-100 ug protein) were
mixed with 10 |XL of 2X sample buffer [0.125 M Tris, pH 6.8,
4% (v/v) SDS, 10% glycerol, 0.02% (w/v) bromophenol blue,
5% (v/v) B-mercaptoethanol]. The mixture was then heated
to 95°C for 3 minutes and loaded on the gel. The molecular
weight standards, which were treated identically as the
sample, were then loaded on the gel. Electrophoresis began
at a constant 100 volts and continued until the dye front
approached the terminus of the gel. After electrophoresis,
the gel was removed from the unit and stained for at least
30 minutes with 0.1% coomassie blue in fixative (40%
methanol, 10% acetic acid). The gel was destained with 40%
methanol:10% acetic acid.
-Nitrogen Mustard Metabolism/Decomposition-
The test reagents metabolism was determined by
moderately modifying recommendations described by Lyttle et
al. (1993). Briefly, solutions of agents 1, 2, and 3 were
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prepared in 0.2 M phosphate buffer, and a solution of
purified GST was added. The final concentration was 8/uM
for the substrates and 0.5//M GSTs. The pH was maintained
at 7.3 for 1 and 7.1 for 2 and 3. Rates of decomposition
were determined by monitoring the disappearance of the test
agents at 37°C in one minute intervals using a Beckman 650
Spectrophotometer at 225nm.
-GST Kinetic Assay-
A GST enzyme assay was executed according to Corrigall
et al. (1989). The reaction mixture contained 3.33 mM
potassium phosphate with 0.1% KCl, 0.5 ug GST, and the
primary (reduced glutathione; GSH) and secondary
(1-chloro,2,4-dinitrobenzene; CDNB) substrates. One
substrate was varied while the other was held at a constant
concentration. The final volume of the reaction mixture
was maintained at 3 ml. This series of experiments was
repeated by alternating the constant and variable
substrates. The optical density was determined at 340 nm
(absorbance maximum of the product) with a Beckman DU-650
spectrophotometer equipped with a kinetics software
program. The initial rates of reaction was monitored in 5
second intervals at 25°C.
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-Peptide mapping-
This analysis was executed as outlined by Fisichella
et al. (1995). Peptide separations were performed on a
Beckman System Gold HPLC equipped with a Beckman 168 Diode
Array Detector. The solvents used were all HPLC grade.
TFA was purchased from Sigma Chemical Company in one
milliliter sealed ampules which were filled with argon.
Hydrochloric acid, protein sequencing grade, was also
purchased in two milliliter sealed ampules from Sigma
Chemical Company. TPCK treated trypsin, suitable for
protein sequencing and peptide mapping, was purchased from
Sigma Chemical Company. HPLC grade acetonitrile and water
were purchased from Fisher. All eluents were stored under
nitrogen.
Treated GST, which was incubated with the test agents
for 24 hours at room temperature, and untreated GST samples
were analyzed. The protein samples were hydrolyzed in 6M
hydrochloric acid for 24 hours at 105°C in evacuated sealed
tubes.
Reduction and carboxymethylation
One micromole GST was solubilized in IM Tris-HCl
containing 6M guanidine, at a concentration of lOmg/ml.
The pH was adjusted to 8.5 with HCl. Ten millimolar DTT,
dissolved in 2ml of the same buffer, was added. The
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mixture was incubated, in the absence of light, at 25°C for
three hours in an evacuated sealed tube. One percent (w/v)
iodoacetic acid, dissolved in 3ml of IM Tris-HCl containing
6M guanidine, was then added. The pH was raised to 8.5 by
addition of NaOH. The mixture was kept in the dark at room
temperature for one hour while maintaining the pH above 8.
Excess iodoacetic acid was then eliminated by the addition
of lOyul 2-mercaptoethanol. The solution was then dialyzed
against water, frozen with liquid nitrogen, and
lyophilized.
Tryptic cleavage of reduced and carboxymethylated GST
suhfragments
One micromole of the lyophilized protein was dissolved
in 20mM ammonium acetate, pH 8.3, containing ImM calcium
chloride, at a concentration of Img/ml. Ninety micrograms
trypsin was dissolved in the same buffer and added. The
solution was incubated at 37°C for four hours. The
digestion was stopped by cooling in liquid nitrogen. The
mixture was immediately lyophilized.
HPLC separation of the tryptic peptide mixture of GST
subfragments
The lyophilized tryptic peptide mixture was dissolved
in aqueous 0.1% TEA, filtered through a Coming's 13mm,
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0.45//m cellulose acetate syringe filter and applied onto a
reverse-phase Vydac TP218 C-18 {4.6itim ID x 25cm, 5//m)
column. The column was eluted at room temperature with
aqueous 100 (v/v)% solvent A [0.1 (v/v)% TFA:99.9 (v/v)%
water] for 5 minutes then with a linear gradient of
increasing solvent B (95.0 (v/v)% acetonitrile: 4.9 (v/v)%
water: 0.1 (v/v) % TFA) to a final concentration of 100%
solvent B in 60 minutes. The flow rate was 1ml per minute.




Determination of the toxic potential of the simulants
Prior to organophosphate treatment, the untreated
HEP-G2 cells were grown over a period of twelve days to
establish confluency. Initial cell growth was minimal
during the first two days, indicative of a lag phase. This
interval was followed by a period of exponential increase
for the next 5-6 days which was indicative of the log-phase
of cell growth. Cell death ensued past the eighth day
(fig. 6). Hence, confluency was attained in 7-8 days.
To determine the toxic potential of the nitrogen
mustard simulants (T230, T231, and T286), HEP-G2 cells were
treated in both dose- and time-response studies with these
agents. The cells were allowed to grow for at least 48
hours prior to treatment. Significant levels of toxicity
(<90% survival) were not observed with up to 240fM T230 in
three hours. On the other hand, treatment with much lower
doses of T231 had a significant effect on cell viability
within 2 hours (fig. 7) . This effect was more pronounced
as both the treatment time and concentration of the test
agent were increased.
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When T286 was used in similar studies, a significant
decrease in viability was observed with as little as 20//M
in 4 hours (fig. 8).
Determination of the mutagenic potential of the simulants
Three strains of Salmonella typhimurium were used for
this assessment. The mutagenicity of the test agents was
tested over a three-log dose range. The first strain used
was TAIOO. This strain possesses the rfa mutation which
causes partial loss of the lipopolysaccharides on the
surface of the bacteria. As such, increased permeability
to large molecules that would not normally cross the cell
wall ensues. In addition, it also possesses the uvrB
mutation to enhance the strain's sensitivity in mutagen
detection (Ames, 1983).
The results showed that in this strain, T230 was
mutagenic when compared to the positive controls. Addition
of the metabolic activation mix (S9) did not significantly
impact its mutagenic potential and there was no dose
response observed over the range of concentrations used.
However, stronger mutagenic capacities were demonstrated by
T231 and T286. Both of these compounds caused a greater
number of net revertants than T230 and both demonstrated
significant dose responses (fig. 9) .
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Figure 9. Reverse mutations from Salmonella typhimurium
strain TAIOO.
NumberofRevertants(straiTA100) -*•MN) N}cnoui o
o
Control
T230(1ug) T230(10ug) T230(100ug) T231(1ug) T231(10ug) T231(100ug) T286(1ug) T286(10ug) T286(1OOug)
Another strain that was used for this study was TA102.
Strain TA102 lacks the described mutations possessed by
TAIOO. In this strain, T230 demonstrated a stronger
mutagenic response in the presence of S9, but little
response without it. There was also a noticeable dose
response between l//g and 10//g, but not between 10//g and
100//g. For T231, a strong mutagenic response was observed
for all doses of the compound used. However, there were no
significant differences in the number of revertants among
the doses and only at the lowest dose used (l//g) was there
a significant difference between the responses obtained
with and without the S9.
T286 also caused a significant number of reversions in
TA 102. However, it should be noted that particularly at
the higher doses used {10//g and lOO/zg), the number of
reversions in the experiments without the S9 metabolic
system were higher than the number obtained in the presence
of S9 (fig. 10).
The third strain utilized for this study was TA98.
Strain TA98 possessed the rfa and uvr mutations described
earlier. The experimental conditions were identical to
those of strains TAIOO and TA102.
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There were no significant differences (data not shown)
between the number of revertants in the presence of the
test agents and the number of spontaneous revertants in the
presence of the solvent (0.2% DMSO).
Inhibition of human acetylcholinesterase by the simulants
The kinetic parameters of AchE were studied to assess
the test compounds' potential as a United States stockpiled
chemical munition. The parameters were assessed by varying
the concentration of the enzyme's substrate,
butyrylthiocholine, concentration between 0.5mM and 5mM.
Multiple enzyme amounts were used to determine optimal
conditions that would facilitate detection of enzyme
activity in the presence of an activator or inhibitor.
Hence, 5yug AchE was used for subsequent inhibitor/effector
studies (fig. 11).
T230 was used as the first effector for AchE. It was
varied between 2(j.q - 8//g. The resulting linear curves
shared a common intercept on the ordinate; however, the
intercepts on the abscissa varied. This demonstrated that
T230 served as a competitive inhibitor of AchE. The
abscissa-intercepts were -0.2797mM“^, -0.2217mM“^,
-0.2181mM“^, and -0.1697inM“^ in the presence of 2//g T230,
4//g T230, 6//g T230, and 8//g T230, respectively (fig. 12) .
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Figure 11. Acetylcholinesterase activity in the absence of
effectors.
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Figure 12, Acetylcholinesterase activity in the presence of
T230.
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The maximal enzymatic rate was determined to be 29.6736
UL“^ ± 5.2509 UL“^ in the presence or absence of the
effector. The K^, however, was determined to be 3.5753mM,
4.5106mM, 4.5851mM, and 5.8932mM as the effector was
increased from 2//g T230 - 8//g T230 as compared to 2.059mM
in the absence of T230.
T231 was used as the second effector in the presence
of 5jUg AchE. The Kj^ did not significantly differ from that
of the uninhibited reaction (fig. 13); however, the
reaction rates were significantly reduced. This occurrence
indicates that T231 was a noncompetitive inhibitor of AchE.
Ordinate-intercepts of 0.0449LU~^, 0.0673LU“^, and
0.1347LU“^ were produced from enzymatic reactions in the
presence of 3.1//g T231, 6.2//g T231, and 12.4//g T231,
respectively. Hence, maximal enzymatic rates were
estimated at 22.27UL“^, 14.86UL“^ and 7.42UL“^ with each
increase of the effector.
One other effector was used, T286. Unlike the
previous linear curves, these curves did not share a point
of intersection in the second quadrant (fig. 14) . An
ordinate of 0.1347UL“^ resulted in the presence of 10.3//g
T286. In addition, an abscissa of -0.8781mM“^ resulted in
the presence of 10.3//g T286. A value of 1.14mM was
estimated for the resulting linear curve in the presence of
the test agent.
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Figure 13. Acetylcholinesterase activity in the presence of
T231.
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Figure 14. Acetylcholinesterase activity in the presence of
T286.
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Purification and characterization of GST from HEP-G2 cells
In order to study the interaction between the putative
biomarker and the test compounds, glutathione S-transferase
was purified to homogeneity from HEP-G2 cells. Glutathione
S-transferase was purified from HEP-G2 human hepatoma cells
by affinity chromatography on cross-linked 4% beaded
epoxy-activated agarose with insolubilized GSH. The 9,000
X g supernatant extract from these cells was applied to a
20 cm X 1.5 cm affinity column, which was eluted step-wise
with three buffers (Buffers A, B, and C) . Figure 15
depicts a typical elution profile.
Elution of the column with buffers B and C resulted in
the detection of two putative forms of GST, identified as
low-affinity (fraction B) and high-affinity (fraction C)
forms. This designation was given to the peaks because of
the relative ionic strength of the buffers needed to elute
each form.
During a typical purification protocol, fraction A
represented 84% of the soluble cytosolic protein placed on
the column while fractions B and C represented 0.64% and
0.35%, respectively. Thus, the GST isoenzymes comprised
less than one percent of the total recovered cytosolic
proteins.
Both fractions B and C exhibited GST activity with the
substrates CDNB and GSH while specific activity with DCNB
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and GSH was negligible (data not shown). Although fraction
C possessed the greater amount of GST activity, both forms
were used as the source of enzyme in subsequent studies.
The electrophoretic mobility of the purified forms was
also examined and the molecular weight of both forms of GST
was determined via SDS-PAGE as described by Laemmli (1970).
The stacking gel and the separating gel concentrations were
3% and 7.5%, respectively. Phosphorylase b (106,000
daltons), Bovine Serum Albumin (80,000 daltons), Ovalbumin
(49,500 daltons) and Carbonic anhydrase (32,500 daltons)
were used as standards for characterization of molecular
size. The low-affinity isoenzyme studied yielded a single
band of 47,969 daltons as compared to the protein markers.
The high-affinity isoenzyme studied yielded a band of
45,115 daltons as compared to the protein markers (Fig.
16). In order to determine the optimal conditions under
which GST would exhibit maximal activity, the substrate
concentrations and pH of the reaction mixture (3.33 inM
potassium phosphate with 0.1% KCl, 1 mM GSH, 5 mM CDNB,
GST, dH20 to final volume of 3 ml) were varied. The pH
profile of the high-affinity form revealed that enzyme
activity is maximal at pH 7.2 (fig. 17) as compared to pH
7.4 (fig. 18) for the low-affinity form.
In addition, the CDNB profile (Fig. 19) revealed that
activity is maximal at a 5 mM concentration for the
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Figure 17. pH profile of GST(C).
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Figure 18. pH profile of GST(B).
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high-affinity form while maximal activity is exhibited at
O.SmM CDNB for the low affinity form (fig. 20). Linearity
was lost above these concentrations of CDNB in the presence
of GSH and optimal pH. Optimal GSH concentrations were
determined to be 3mM for the high affinity form (fig. 21)
and O.SmM for the low affinity form (fig. 22). Hence, the
optimal conditions for kinetic analysis of the high
affinity form were defined as 5 mM CDNB and 3 mM GSH
representing saturating substrate levels. pH 7.2, with
0.3/^g protein. The low-affinity form was optimally assayed
in the presence of 0.6mM CDNB, O.SmM GSH, pH 7.4 with 0.3//g
protein. These conditions were maintained throughout all
kinetic assays.
Metabolism of simulants by GST
The metabolism of T230, T231, and T286 was tested in
the presence and absence of GST. Spontaneous decomposition
of the test agents was negligible. However, metabolism of
the test compounds did occur in the presence of GST.
The metabolism of T230 was monitored at an absorbance
of 225nm in the presence of 2.55//g GST(B). During the
first few minutes of the reaction, there was no significant
metabolism of T230 (via substrate disappearance). However,
after five minutes the rate of metabolism increased
significantly and linearly for eighteen minutes (fig. 23).
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Figure 20. ODNB profile of GST(B).












Figure 22. GSH profile of GST(B).
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Figure 23. Metabolism of compound T230 by GST(B).
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Conversely, metabolism of T230 by the high-affinity GST(C)
was nearly instantaneous (fig. 24) . Comparatively, the
metabolic rate for T230 by GST(B) was 0.064//M/min while
that for GST(C) was 0.425//M/min.
T231 metabolism was monitored in the presence of
GST(B) and GST(C). Its metabolism by GST(B) began
immediately and was linear for the first five minutes of
the assay (fig. 25). Using this portion of the curve, the
resulting reaction rate was 0.078//M/min. When GST(C) was
used, the reaction went to essential completion in less
than two minutes (fig. 26) . The calculated reaction rate
was 1. IlOyuM/min.
The metabolism of T286 was also monitored in the
presence of GST(B) and GST(C). Unlike the other test
compounds, T286 metabolism by GST(B) was biphasic,
beginning very slowly, but then becoming more rapid as the
reaction time increased (fig. 27) . However, T286
metabolism by GST(C) was extremely rapid (fig. 28), as was
the case with the other test compounds. The resulting
reaction rates during the linear phase of both reactions
were 0.023//M/min for GST (B) and 0.8025/uM/min for GST(C).
These findings are summarized in table 2.
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Figure 24. Metabolism of compound T230 by GST(C).
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Figure 25. Metabolism of compound T231 by GST(B).
Time (min.)
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Figure 26. Metabolism of compound T231 by GST(C).
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Figure 27. Metabolism of compound T286 by GST(B).
Time (rrin.)
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Figure 28. Metabolism of compound T286 by GST(C) .
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Kinetic analysis of GST in the presence/absence of the
simulants
Initial rate kinetics with varying GSH, in the
presence of 0.3//g GST(B), gave a pattern of intersecting
linear curves in the presence/absence of test agent T230
where the intersection occurred in the second quadrant of
the Cartesian plane. The double reciprocal plot generated
in the absence of any test agent yielded kinetic parameters
of 8.210//M ± 0.671//M as its Kj^ and 53.125^iM/min/mgQ2.p ±
4.166//M/min/mgQ2ip as its maximal specific activity (fig.
29) . The more than doubled in the presence of the test
agent yielding a value of 18.650//M ± 3.531//M (fig. 29).
The maximal rate, of the enzymatic reaction in the
presence of the effector was reduced to 31.250yuM/min/mgQ2ij,
± 6.250/^M/min/mgQ2rp.
Kinetic parameters were also determined by monitoring
initial rate kinetic reactions with varying CDNB in the
presence of 0.3//g GST(B) and presence/absence of test agent
T230 (fig. 30). These double reciprocal plots were
non-parallel and intersect in the third quadrant of the
cartesian plane, just below the abscissa. The enzymatic
reaction in the absence of any effectors yielded a value
of 53.7 6//M ± 2.486//M and a value of 1104.166//M/min/mgQ2.p
± 165.624/i.M/min/mgQ2x*
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Figure 29. GST(B) activity in the presence of T230 while
varying GSH.
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However, the enzymatic reaction in the presence of the
effector yielded a value of 37.040/zM ± 1.813yuM and a Vjj^
value of 229.166/^/min/mgQ2.p ± 50.000/uM/min/mgQ2.j..
Test agent T231 was also used as an effector for
kinetic assays in the presence of 0.3//g GST(B) and varying
GSH and CDNB concentrations. Kinetic plots with varied GSH
concentrations produced a value of 5.290//M ± 1.166/zM at
a maximal rate of 8.333//M/min/mgQ2T * 2.083/iM/min/mgQ2'j'
(fig. 31). Again, these curves are non-parallel and
intersect in the third quadrant of the Cartesian plane.
Kinetic plots with varied CDNB concentrations produced a Kj^
value of 43.660/^M ± 0.363/jM at a maximal rate of
282.291//M/min/mgQ2T * 8.333//M/min/mgQ2T (fi?* 32).
The third effector used in these studies was test
agent T286. The kinetic assay was again monitored in the
presence of 0.3//g GST(B) and varying GSH and CDNB
concentrations. Double-reciprocal plots suggested a Kj^
value of 48.7 80juM ± 2.133fM and value of
19.791//M/min/mgQ2T ± 4.166//M/min/mg(22T with varying GSH
concentrations (fig. 33). These linear plots intersected
in the second quadrant. Varied CDNB concentrations yielded
a Kjj^ value of 114.940/zM ± 10.986^4M and value of
13 9.583//M/min/mgQ2T ± 14.53yuM/min/mgQ2T (fig* 34). This
plot also intersected with its control in the second
quadrant.
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Figure 31. GST(B) activity in the presence of T231 while
varying GSH.
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Figure 32. GST(B) activity in the presence of T231 while
varying CDNB.
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Figure 33. GST(B) activity in the presence of T286 while
varying GSH.
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Figure 34. GST(B) activity in the presence of T286 while
varying CDNB.
1/SpecificActiv ty(umoi/min/mgQST(B))^
The aforementioned test agents were also monitored in
the presence of isoform GST(C). Initial rate kinetics with
varying GSH, in the presence of O.S^ug GST(C), gave a
pattern of intersecting linear curves in the
presence/absence of test agent T230 where the intersection
occurred on the ordinate of the Cartesian plane. The
double reciprocal plot generated in the absence of any test
agent yielded kinetic parameters of 4.390/zM ± 0.264//M as
its Kj^ and 164 5.833/^M/min/mgQ2.j. ± 12. S^M/min/rngQ^ij as its
maximal rate (fig. 35) . Over an 8-fold increase in the
resulted in the presence of this test agent (T230) yielding
a value of 38.020//M ± 1.485/iM (fig. 35). The
maximal rate, of the enzymatic reaction in the presence of
the effector was unchanged at 1645.833/^/min/mgQ2.p ±
12.5MM/min/mgQ2.p.
Kinetic parameters were also determined by monitoring
initial rate kinetic reactions with varying CDNB in the
presence of 0.3//g GST (C) and presence/absence of test agent
T230 (fig. 36). These double reciprocal plots were
non-parallel and intersected on the ordinate of the
Cartesian plane. The enzymatic reaction in the absence of
any effectors yielded a value of 21.740//M ± 0.049;uM and













However, the enzymatic reaction in the presence of the
effector yielded a value of 200.000/uM ± 9.545/iM while
the remained unchanged.
Test agent T231 was also used as an effector for
kinetic assays in the presence of O.S^g GST(C) and varying
GSH and CDNB concentrations. Kinetic plots with varied GSH
concentrations produced a value of 2.390//M ± 0,252fM at
a maximal rate of 822.916//M/min/mgQ2rji ± 16.666//M/min/mgQ2ip
(fig.37). This curve is parallel to the double reciprocal
plot generated in the absence of T230. Hence, these curves
do not share a common point of intersection (fig. 37) .
Kinetic plots with varied CDNB concentrations produced a Kj^
value of 217.390/^ ± 5.780/iM at a maximal rate of
239.58 3//M/min/mgQ2rj, ± 36.458//M/min/mgQ2T 38)*
The third effector used in these studies was test
agent T286. The kinetic assay was again monitored in the
presence of 0.3//g GST(C) and varying GSH and CDNB
concentrations. Double-reciprocal plots suggested a K^^^
value of 5.290//M ± 0.361//M and value of
12 60.416//M/min/mgQ2T * 132.291//M/min/mgQ2T with varying GSH
concentrations (fig. 39) . This plot was not parallel with
that of the control and intersected in the second quadrant.
Varied CDNB concentrations yielded a K^^^ value of 125/^M ±










GST(C) activity in the presence of T231 while
CDNB.
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This plot also intersects with its control in the second
quadrant. Table 3 summarizes the results of these kinetic
studies.
HPLC analysis
Compounds T230, T231, and T286 were separately
incubated with GST. Tryptic fragments were eluted with an
increasing gradient of 0% solvent B to 100% solvent B in 60
minutes. The peptide maps generated from treated GST and
untreated GST were then compared. Figure 41 depicts the
peptide maps of GST(B) in the presence and absence of T230.
The two chromatograms were then aligned prior to analysis.
Alignment revealed that the maps were greatly
superimposable. However, there was a peak shift from a
retention time of 23.11 minutes in the absence of T230 to
23.00 minutes in the presence of T230.
On the other hand, figure 42 depicts the peptide maps
of GST(B) in the presence and absence of T231. The two
chromatograms were again aligned prior to analysis.
Alignment revealed that the maps were also greatly
superimposable. However, there were four peak shifts.
These shifts took place at 26.652 minutes, 27.537 minutes,
28.034 minutes, and 28.307 minutes in the absence of T231
to 26.594 minutes, 27.471 minutes, 27.943 minutes, 28.266
minutes respectively, in the presence of T231.
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K„ (mM) (/.iM/min/mgosr) (MM/min/mgo^)
8.21±0.67 53.13±4.17 4.39±0.26 1645.83±12.50
18.65±3.53 31.25±6.25 38.02±1.49 1645.83±12.50
5.29±1.17 8.33±2.08 2.39±0.25 822.92±16.67
























Figure 41. Peptide map of GST(B) in the presence/absence of
T230. Panel B is an exploded view of a time interval in
panel A,
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Figure 42. Peptide map of GST(B) in the presence/absence of
T231. Panel B is an exploded view of a time interval in
panel A.
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T286 did not produce any noticeable shifts upon
incubation with GST(B). Similarly, there
measurable differences between the treated and









The cell toxicity studies suggest that T286 is more
toxic than T231 which is more toxic than T230. As
expected, longer exposure times with the test agents gave
higher levels of toxicity. This occurrence is consistent
for a time course of activation for compounds two and three
(Lyttle, 1993). HEP-G2 cells were treated with all three
compounds for identical periods of time. However, T230 did
not produce significant levels of toxicity {<90% survival).
This occurrence reveals that HEP-G2 cells are tolerant of
T230 and/or its byproducts. One would expect a higher
level of tolerance than other cell types, since human liver
cells are extensively involved in detoxification. However,
this phenomenon is not unique to liver cells since it also
occurs in human colon carcinoma cell lines. Hence,
toxicity of compounds T231 and T286 can be attributed to
the liberation of the halogenated phosphate-metabolite
(Lyttle, 1993). Colvin and Holden (1981) suggested that
this liberated metabolite can interact with macromolecules,
probably at the DNA level. As such, the mutagenic capacity
of the munition simulants was assessed via the Ames test.
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Of the many tests currently available/ the Ames
Salmonella /microsome assay is the single most widely used
and most thoroughly validated test in genetic toxicology
(Kier et al., 1986; Myers et al., 1987; Knuiman et al.,
1987; Margolin et al., 1989; Krewski et al., 1993).
Reverse mutations from auxotrophic bacterial cells (His“),
which require histidine for growth, to prototrophic
histidine-independent cells (His'*') are detected.
Salmonella typhimurium were cultured in soft agar with
trace amounts of histidine to permit residual growth of
auxotrophic cells (Maron and Ames, 1983; Krewski et al.,
1993) . Hence, these cells form a background lawn of
microcolonies. A reduction in the density of these
microcolonies, in the presence of the test agents, would be
indicative of cell toxicity.
Metabolic activation of the test chemicals may be
achieved via preincubation with exogenous mammalian
enzymes and added to the suspension in which the cells are
grown (Maron and Ames, 1983) . This aim is commonly
attained via the use of 9,000 x g homogenate (S9) of rat
liver cells (Maron and Ames, 1983; Kier et al., 1986; Myers
et al., 1987; Knuiman et al., 1987; Margolin et al., 1989;
Krewski et al., 1993). In this study, Aroclor 1254 rat
liver S9 was used to achieve metabolic activation.
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Even so, metabolic activation is attainable with Hep-G2
supernatant (Duverger-van Bogaert et al., 1993). However,
enzyme activities are lower than Aroclor 1254 rat liver S9
which may result in reduced sensitivity (Duverger-van
Bogaert et al., 1993).
The tester strains TA98, TAIOO, and TA102 of
Salmonella typhimurium were used as described by Ames and
Maron (1983). These histidine-requiring strains possess
different types of mutations in the histidine operon (Ames
and Maron, 1983). Other mutations, such as rfa, causes
partial loss of the lipopolysaccharides on the surface of
the bacteria. As such, increased permeability to large
molecules that would not normally cross the cell wall
ensues. Strains TA98 and TAIOO possess this mutation. In
addition, they also possess the uvrB mutation. This
mutation is a deletion of a gene essential for the DNA
repair system, which enhances the strain's sensitivity in
mutagen detection (Ames, 1983). Strain TA102, however,
lacks this mutation. Hence, TA102 was used to test
potential mutagens that may require an intact excision
repair system. TA102 also lacks the rfa mutation. All
three strains possess the R-factor plasmid pKMlOl, which
increases chemical and spontaneous mutagenesis by enhancing
an error-prone DNA repair system that is normally present
in these organisms (Ames and Maron, 1983).
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In addition, strains TAIOO and TA102 were designed to
detect base-pair substitutions in the DNA sequence while
strain TA98 detects frameshift mutations (Ames and Maron,
1983).
For these series of studies, approximately 10° cells
were plated for each experiment. Each experiment included
positive controls which yielded a dense background lawn
among the revertants. This lawn was present in all tests
at approximately the same density. Hence, the bacterial
cells were exposed to sub-lethal doses of the test agents.
The maximal number of revertants detected did not exceed
2x10^ for any of the test agents at their respective
dosages (refer to fig. 9 & 10) . The appearance of these
revertants suggest that the test agents utilized in this
study are indeed mutagenic. However, to assess the potency
of their mutagenic capacity, one must consider the strains
in which these reversions occurred. Strain TA98, which
lacks a gene essential for DNA repair, did not yield any
significant revertants upon incubation with the test agents
(not shown). This occurrence suggests that perhaps an
intact DNA repair system is required, or a frameshift event
is nonexistent. The results obtained from the use of
strain TAIOO (fig. 9), which also lacks a gene essential
for DNA repair, clarifies this outcome considerably since
revertants were generated. These findings suggest that the
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compounds were mutagenic at the doses tested, preferably
via a base-pair substitution as opposed to a frameshift
event. In addition, metabolic activation seem to enhance
the mutagenic capacity of test agents T286 and T231.
Strain T102, unlike the former strains, possessed an intact
DNA repair system and was able to generate revertants in
the presence of the test agents (fig. 10). TA102 generated
more revertants than TAIOO. Hence, an intact DNA-repair
system is preferential for mutagenicity. Interestingly,
metabolic activation does not appear to be preferential for
compounds T231 and T286.
Since AchE is targeted by common chemical munitions,
such as sarin and tabun, assessing the influence of our
test agents on AchE was of interest. Hence, it is
important to verify that these novel compounds react
similarly to true munitions. Conventionally, serum
cholinesterase measurement had been used to monitor
excessive exposure to organophosphate insecticides as well
as assess liver function (Silk et al., 1979). In this
study, cholinesterase activity was measured in order to
assess the test agents utilized. The munition simulants
were selected on the basis of their attenuated toxicity.
As expected, the three test agents were indeed
inhibitory of AchE activity. T230 exhibited kinetics
indicative of competitive inhibition (fig. 12).
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The maximal rate remained constant with a four-fold
increase in inhibitor concentration while the enzyme's
affinity for its substrate varied. On the other hand, T231
exhibited kinetics indicative of noncompetitive inhibition
(fig. 13) . The of the inhibited reaction did not
significantly differ from that of the uninhibited reaction
while the reaction velocity was altered. T286 exhibited
kinetics that may be best explained by mixed-inhibition
(Segal, 1975). Both the and reaction rates were
altered. However, these alterations were not to the same
extent at higher inhibitor concentrations (fig. 14) . This
may be explained by the presence of a phenyl group, which
is not present in T230 and T231.
It is clear that these compounds interact with
acetylcholinesterase. The results suggest that T230
directly binds AchE at the enzyme's catalytic site.
Hence, the enzyme's free form, E, is targeted by T230. On
the other hand, the interaction between T231 and AchE is
more complex. This agent possesses the capacity to bind
the free enzyme (E) and the substrate bound enzyme (ES) .
However, the predominate species in the presence of T286
and AchE may be the ESI (enzyme-substrate-inhibitor)
complex. In addition we attempted to demonstrate
interaction of the putative biomarker with the simulants
via enzymatic metabolism of the simulants.
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In the presence of the enzyme, the parent compounds were
metabolized to their respective by-products (fig. 5).
GST(C) metabolized the test agents more efficiently than
GST(B). However, T286 appears to severely inhibit GST
activity. This occurrence was not expected. One would
have expected that the phenyl group of T28 6 to act as a
strong electron withdrawing group, due to the
delocalization of its pi electrons. This phenomenon should
facilitate enzymatic proton extraction as reported by
Lyttle and colleagues (1993). However, the presence of the
phenyl group seems to interfere with enzyme activity. Even
so, T286 was metabolized most efficiently by both forms of
the enzyme. In addition, it is interesting to note the
apparent biphasic metabolism of the simulant in the
presence of GST(B). The rate of metabolism was initially
low; however the rate increased as time progressed. This
occurrence may be due to steric hindrance of the simulant.
Optimal interaction between the active site of GST and the
simulant may be limited by the bulky nature of the
simulant. As such, the initial reaction would be rate
limiting. This type of interaction would account for the
apparent lag phase of the reaction (See fig. 27).
Another interesting, seemingly bi-phasic, reaction is
that of the pH optima of GST(C). Seemingly, there is more
than one pH optima, pH 6.8 and pH 7.2.
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This occurrence may be explained by the ionization of
multiple amino acids, at GST’s active site, which are
involved in GSH conjugation. Awasthi et al., (1987) report
that histidine is responsible for GSH conjugation. It has
also been suggested that an arginine residue is associated
with GSH binding and anion recognition (Schasteen et al.,
1983). In addition, Kong et al. (1992) reported that a
tyrosine residue is responsible for GSH ionization.
The GST kinetic parameters in the presence/absence of
the simulants, obtained form the double-reciprocal plots,
provided some insight into the mechanism of enzyme-effector
interaction. The double-reciprocal plot generated in the
presence of isoform GST(B), varied [GSH], and test agent
T230 resulted in an increase in and a reduction in as
compared to that of the control. These curves intersected
above the abscissa in the second quadrant. Segel suggested
that this type of kinetics is indicative of mixed type
inhibition (1975). This system may be described as one in
which El (Enzyme-Inhibitor complex) has a lower affinity
than E (free/ unbound Enzyme) for S (free/unbound
substrate), and the ESI (Enzyme-Substrate-Inhibitor)
complex is nonproductive (Segel, 1975). The equilibria
describing this system could be considered a mixture of
partial competitive inhibition and pure noncompetitive
inhibition (Segel, 1975).
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Hence, one could infer that the effector interacted with
catalytic and non-catalytic sites of the enzyme under the
assayed conditions. However, when the varying substrate
was changed to CDNB, both the and were reduced. Even
so, Segel suggested that this phenomenon is indicative of
mixed-type inhibition where the effector/inhibitor convert
the free enzyme E, to an El form which has an increased
affinity for the substrate (1975). The resulting ESI forms
product at a reduced rate as compared to ES (Segel, 1975).
Hence, the ESI form is partially inhibitive. This type of
inhibition may be considered a deviant of uncompetitive
inhibition since the inhibitor did not impact the Kj^ by
exactly the same factor as it did the (Segel, 1975) .
Collectively, these plots suggest that enzyme-substrate
interaction is not ordered. Again, one could infer that
the inhibitor interacted with catalytic and non-catalytic
sites of the enzyme under the assayed conditions.
The double-reciprocal plots generated in the presence
of test agent T231 with varying GSH, isoform GST(B) or
GST(C) yielded similar results as did the assays with
varying concentrations of CDNB in the presence of test
agent T230 with isoform GST(B). Both the values and
values were reduced as compared to the controls. On the
other hand, the kinetic plots generated in the presence of
varying concentrations of CDNB with test agent T231 or test
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agent T28 6 resulted in unchanged values and reduced Vj^
values as compared to their respective controls. These
plots suggested that these test agents were non-competitive
inhibitors. The intersection of these curves, along with
their control, occur on the abscissa. The possible enzyme
forms present may be represented as E, El or ESI. These
forms complexed to the inhibitor exhibited reduced
activity. The unchanging value (fig. 33 & 34) indicated
that the enzyme forms present (E and El), which can combine
with substrate (CDNB), have equal affinities for CDNB
(Segel, 1975) . The apparent value, therefore, results
from the distribution of available enzyme between the "full
affinity" and "no affinity" forms (Segel, 1975). Again,
the results from the kinetic assays in the presence of
isoform GST(C), and test agent T286 were similar to those
of the kinetic assays in the presence of isoform GST(B),
test agent T230 and varying [GSH]. In addition, kinetic
assays with varying [CDNB] in the presence of test agent
T231 and isoform GST(C) was suggestive of a mixture of
partial competitive inhibition and pure noncompetitive
inhibition (Segel, 1975) .
Kinetic plots in the presence of isoform GST(C) and
T230 yielded kinetic parameters where remained unchanged
and increased as compared to the controls.
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This phenomenon is indicative of competitive inhibition
(Segel, 1975). Since competitive inhibitors can be viewed
as substances that combine with enzymes to prevent
substrate binding, they may be regarded as mutually
exclusive (Segel, 1975). It is this exclusion that affords
the inference of catalytic interaction of the test agent
T230 with the enzyme. Because competitive inhibitors
combine with free enzyme, this type of inhibition is
usually indicative of obligatory binding. However, since
competitive inhibition resulted in the presence of both
substrates in excess, separately, then the interaction
between substrates and enzyme is not preferential. Hence,
the enzyme exhibits random binding of its two substrates,
GSH and CDNB.
Since GST is inhibited by these compounds, it was of
interest if the enzyme was structurally modified via
interaction with the organophosphates. Potent alkylating
agents, such as mustards, can be detoxified by conjugation
with glutathione (Dirven et al., 1994). However, little is
known about the GST-dependent biotransformation of
alkylating agents. Even less is known about the structural
modification of GST by potent alkylating agents. Even so,
it is not uncommon for GST to be covalently modified by
the compounds which they metabolize (Brown and Gandolfi,
1994).
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Hence, protein mapping of GST was employed to study this
phenomenon in the presence and absence of the simulants.
Upon comparison of the peptide maps, it was evident
that the maps generated with GST{C) were similar. No
measurable differences were noted. The same was true for
the GST(B) map in presence and absence of T286. However,
peak shifts were detected for the GST(B) maps in the
presence of T230 and T231. These shifts would be
indicative of structural modifications in the enzyme. It
is interesting to note that the shifts that occurred
resulted in earlier eluted peaks. This increased polarity
of the peptides may be due to modification of its residues.
Since, organophosphates are notable for their
phosphorylation capacity, it is conceivable that the
residues were phosphorylated, thereby increasing their
hydrophilicity. The major metabolites of the simulants, as
defined by Lyttle et al. (1993), were a phosphorylated
metabolite and an alkyl group. It is unlikely the alkyl
group would cause a downstream shift of the eluted peaks
because of its size and hydrophobicity. Both factors would
influence an upstream shift of the peaks. Hence, because
of the larger size of the alkyl group, one would expect an
increase in retention of the peptides due to molecular
sieve by the column. In addition, because of its lower
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polarity, one would also expect an increase in retention
since the gradient becomes increasingly nonpolar with time.
The application of fingerprinting to chemical
modification is certainly not unique and can be
instrumental in protein/peptide analysis (Fullmer and
Wasserman, 1979; Rubinstein et al., 1979; Burdon and
Knippenberg, 1989; Christianson and Paech, 1994; Glocker et
al., 1994; Battersby et al., 1995; Fisichella et al.,
1995) . In this study, chemical and enzymatic cleavages
were employed. SDS-PAGE of our samples revealed ~48k;d
polypeptides. Direct digestion with trypsin would give
rise to a complex mixture of peptides that would be
difficult to separate by HPLC. A combination of chemical
and enzymatic cleavages was employed because this approach
would give better separation and hence, extended
reproducibility of the tryptic fragments. Tryptic maps of
organophosphate treated and untreated GST were generated
and compared as a measure of structural integrity. The
retention times of the peaks were not employed in the
analysis in an attempt to minimize errors. Unfortunately,
retention times cannot be used to differentiate closely
related peptides (Christianson and Paech, 1994) . Factors
such as solvent equilibration and temperature fluctuations
can cause retention time shifts in the range of seconds
(Christianson and Paech, 1994). Thus, retention times were
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used solely as a means of peak identification. In order to
obtain a positive differentiation of the peptides, the
compared chromatograms were first aligned. This alignment
would compensate for absolute shifts in retention times.
Hence, the effects of temperature fluctuations and solvent





Glutathione S-transferases are ubiquitous enzymes that
catalyze the conjugation of glutathione with electrophilic
compounds as a cellular defense mechanism in dealing with
xenobiotics and reactive intermediates (Boyer, 1989). GST
may also play an important role as an index of cirrhosis
(Beckett et al., 1987; Harrison et al., 1990), chronic
active hepatitis (Sherman et al., 1983), paracetamol
poisoning (Beckett et al., 1989), birth asphyxia (Beckett
et al., 1989) ethanol ingestion (Hayes et al., 1990), and
halothane exposure (Hussey et al., 1988). Increased
susceptibility to myelodysplastic syndrome has also been
shown with genetic defects of the GST Ml and GST T1 genes
(Chen et al., 1996). In this study, we have shown that GST
may also serve as an index of organophosphate exposure. In
addition to inhibition of enzyme activity. GST is also
structurally modified in the presence of our chemical
agents. These two quantifiable factors make GST an
excellent candidate as a biomarker of exposure.
We have also shown that our simulants are indeed
cytotoxic to human hepatic (HEP-G2) cells. T286 is more
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toxic than T231 which is more toxic than T230. The
increased toxicity of T231 and T286 may be attributed to
the liberation of the halogenated phosphate-metabolite
(Lyttle, 1993).
In addition to the cytotoxic nature of these
simulants, they are also genotoxic. The mutagenic capacity
of these compounds appears to act via base-pair
substitutions. Metabolic activation is not a prerequisite
for mutagenicity.
The simulants also inhibit acetylcholinesterase. This
occurrence is the lethal hallmark of chemical munitions
such as sarin and tabun, which predominates the US
ammunition stockpiles. AchE interacts with the simulants
via the ES complex and in its free form, E. The putative
biomarker, glutathione s-transferase, also interact with
the organophosphates via the ES complex and in its free
form. In the presence of this enzyme, the parent compounds
are metabolized to their respective by-products. GST(C)
metabolizes the test agents more efficiently than GST(B).
The kinetic studies suggest that both isoforms, GST(B) and
GST{C), do not exhibit preferential binding with their
substrates. Even so, the test compounds were inhibitory of
GST activity. This occurrence was noted with both
acetylcholinesterase and glutathione s-transferase.
Ill
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